Literature DB >> 11773406

Relative neurotropism of a recombinant rhabdovirus expressing a green fluorescent envelope glycoprotein.

Anthony N van den Pol1, Kevin P Dalton, John K Rose.   

Abstract

A new recombinant vesicular stomatitis virus (rVSV) that expresses green fluorescent protein (GFP) on the cytoplasmic domain of the VSV glycoprotein (G protein) was used in the mouse as a model for studying brain infections by a member of the Mononegavirales order that can cause permanent changes in behavior. After nasal administration, virus moved down the olfactory nerve, first to periglomerular cells, then past the mitral cell layer to granule cells, and finally to the subventricular zone. Eight days postinoculation, rVSV was eliminated from the olfactory bulb. Little sign of infection could be found outside the olfactory system, suggesting that anterograde or retrograde axonal transport of rVSV was an unlikely mechanism for movement of rVSV out of the bulb. When administered intracerebrally by microinjection, rVSV spread rapidly within the brain, with strong infection at the site of injection and at some specific periventricular regions of the brain, including the dorsal raphe, locus coeruleus, and midline thalamus; the ventricular system may play a key role in rapid rVSV dispersion within the brain. Thus, the lack of VSV movement out of the olfactory system was not due to the absence of potential for infections in other brain regions. In cultures of both mouse and human central nervous system (CNS) cells, rVSV inoculations resulted in productive infection, expression of the G-GFP fusion protein in the dendritic and somatic plasma membrane, and death of all neurons and glia, as detected by ethidium homodimer nuclear staining. Although considered a neurotropic virus, rVSV also infected heart, skin, and kidney cells in dispersed cultures. rVSV showed a preference for immature neurons in vitro, as shown by enhanced viral infection in developing hippocampal cultures and in the outer granule cell layer in slices of developing cerebellum. Together, these data suggest a relative affinity of rVSV for some neuronal types in the CNS, adding to our understanding of the long-lasting changes in rodent behavior found after transient VSV infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11773406      PMCID: PMC135838          DOI: 10.1128/jvi.76.3.1309-1327.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge.

Authors:  A Roberts; E Kretzschmar; A S Perkins; J Forman; R Price; L Buonocore; Y Kawaoka; J K Rose
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

2.  Selective infections of olfactory and respiratory epithelium by vesicular stomatitis and Sendai viruses.

Authors:  B Lundh; K Kristensson; E Norrby
Journal:  Neuropathol Appl Neurobiol       Date:  1987 Mar-Apr       Impact factor: 8.090

3.  Pseudorabies virus expressing enhanced green fluorescent protein: A tool for in vitro electrophysiological analysis of transsynaptically labeled neurons in identified central nervous system circuits.

Authors:  B N Smith; B W Banfield; C A Smeraski; C L Wilcox; F E Dudek; L W Enquist; G E Pickard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

4.  Vesicular stomatitis virus (VSV) therapy of tumors.

Authors:  S Balachandran; G N Barber
Journal:  IUBMB Life       Date:  2000-08       Impact factor: 3.885

5.  Polarized sorting of viral glycoproteins to the axon and dendrites of hippocampal neurons in culture.

Authors:  C G Dotti; K Simons
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

6.  Murine central nervous system infection by a viral temperature-sensitive mutant: a subacute disease leading to demyelination.

Authors:  M C Dal Canto; S G Rabinowitz
Journal:  Am J Pathol       Date:  1981-03       Impact factor: 4.307

7.  Kinetics of virus spread and changes in levels of several cytokine mRNAs in the brain after intranasal infection of rats with Borna disease virus.

Authors:  V Shankar; M Kao; A N Hamir; H Sheng; H Koprowski; B Dietzschold
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

8.  A new cationic liposome reagent mediating nearly quantitative transfection of animal cells.

Authors:  J K Rose; L Buonocore; M A Whitt
Journal:  Biotechniques       Date:  1991-04       Impact factor: 1.993

9.  Interferon protects neurons in culture infected with vesicular stomatitis and herpes simplex viruses.

Authors:  L F Tsukamoto; R W Price
Journal:  J Neurol Sci       Date:  1982-10       Impact factor: 3.181

10.  Cytopathic effects in mouse neuroblastoma cells during a non-permissive infection with a mutant of vesicular stomatitis virus.

Authors:  B J Dille; J V Hughes; T C Johnson; S G Rabinowitz; M C Dal Canto
Journal:  J Gen Virol       Date:  1981-08       Impact factor: 3.891

View more
  70 in total

Review 1.  Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates.

Authors:  Guido Wollmann; Koray Ozduman; Anthony N van den Pol
Journal:  Cancer J       Date:  2012 Jan-Feb       Impact factor: 3.360

2.  Anterograde or Retrograde Transsynaptic Circuit Tracing in Vertebrates with Vesicular Stomatitis Virus Vectors.

Authors:  Kevin T Beier; Nathan A Mundell; Y Albert Pan; Constance L Cepko
Journal:  Curr Protoc Neurosci       Date:  2016-01-04

3.  Lassa-vesicular stomatitis chimeric virus safely destroys brain tumors.

Authors:  Guido Wollmann; Eugene Drokhlyansky; John N Davis; Connie Cepko; Anthony N van den Pol
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

4.  Canine distemper virus uses both the anterograde and the hematogenous pathway for neuroinvasion.

Authors:  Penny A Rudd; Roberto Cattaneo; Veronika von Messling
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

5.  rVSV(M Delta 51)-M3 is an effective and safe oncolytic virus for cancer therapy.

Authors:  Lan Wu; Tian-gui Huang; Marcia Meseck; Jennifer Altomonte; Oliver Ebert; Katsunori Shinozaki; Adolfo García-Sastre; John Fallon; John Mandeli; Savio L C Woo
Journal:  Hum Gene Ther       Date:  2008-06       Impact factor: 5.695

6.  Enhanced cytomegalovirus infection of developing brain independent of the adaptive immune system.

Authors:  Anthony N van den Pol; Jon D Reuter; Justin G Santarelli
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

7.  Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting.

Authors:  Elizabeth J Kelly; Rebecca Nace; Glen N Barber; Stephen J Russell
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

8.  Some attenuated variants of vesicular stomatitis virus show enhanced oncolytic activity against human glioblastoma cells relative to normal brain cells.

Authors:  Guido Wollmann; Vitaliy Rogulin; Ian Simon; John K Rose; Anthony N van den Pol
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

9.  Replication of many human viruses is refractory to inhibition by endogenous cellular microRNAs.

Authors:  Hal P Bogerd; Rebecca L Skalsky; Edward M Kennedy; Yuki Furuse; Adam W Whisnant; Omar Flores; Kimberly L W Schultz; Nicole Putnam; Nicholas J Barrows; Barbara Sherry; Frank Scholle; Mariano A Garcia-Blanco; Diane E Griffin; Bryan R Cullen
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

10.  The olfactory nerve has a role in the body temperature and brain cytokine responses to influenza virus.

Authors:  Victor H Leyva-Grado; Lynn Churchill; Joseph Harding; James M Krueger
Journal:  Brain Behav Immun       Date:  2009-10-29       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.